Literature DB >> 3183428

Epidemiological studies of Streptococcus pneumoniae in infants: antibody to types 3, 6, 14, and 23 in the first two years of life.

B M Gray1, H C Dillon.   

Abstract

Antibodies to pneumococcal types 3, 6, 14, and 23 were measured in sera from 78 infants prospectively studied from birth. Mean levels of antibodies to capsular antigens were 2-4 micrograms/mL, with no overall differences between carriers and noncarriers of given types. Serial serum samples were studied in selected infants to more precisely define the antibody response in relation to specific pneumococcal colonization and infection. Although some infants had little antibody, and made little in response to exposure, others had demonstrable antibody at the onset of acute otitis media. The highest levels were seen following repeated exposure. After an initial or secondary response, levels declined with or without continued nasopharyngeal carriage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3183428     DOI: 10.1093/infdis/158.5.948

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Bacterial profile of the oropharynx in infants: an assessment of the confounding factors for colonization.

Authors:  Dinesh M Nayak; Naveen Kumar; Nalini Bhaskaranand; Chandrika Nayak
Journal:  Indian J Pediatr       Date:  2011-02-22       Impact factor: 1.967

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  The burden of pneumococcal meningitis in Austrian children between 2001 and 2008.

Authors:  D S Klobassa; B Zoehrer; M Paulke-Korinek; U Gruber-Sedlmayr; K Pfurtscheller; V Strenger; A Sonnleitner; R Kerbl; B Ausserer; W Arocker; W Kaulfersch; B Hausberger; B Covi; F Eitelberger; A Vécsei; B Simma; R Birnbacher; H Kurz; K Zwiauer; D Weghuber; S Heuberger; F Quehenberger; H Kollaritsch; W Zenz
Journal:  Eur J Pediatr       Date:  2014-01-14       Impact factor: 3.183

4.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Measurement of pneumococcal capsular polysaccharide serotype-specific immunoglobulin G in human serum, a method for assigning weight-based units to proposed reference sera.

Authors:  K M Rudolph; A J Parkinson
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

6.  Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4.

Authors:  D M Musher; B Johnson; D A Watson
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

7.  Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.

Authors:  David Navarro; Amparo Escribano; Laura Cebrián; Concepción Gimeno; Leonor García-Maset; Juan García-de-Lomas
Journal:  Clin Vaccine Immunol       Date:  2006-06

8.  Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.

Authors:  D E Briles; C Forman; J C Horowitz; J E Volanakis; W H Benjamin; L S McDaniel; J Eldridge; J Brooks
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  Seroprevalence of immunoglobulin M (IgM) and IgG antibodies to polysaccharides of Streptococcus pneumoniae in different age groups of Ecuadorian and German children.

Authors:  H Brüssow; M Baensch; J Sidoti
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

10.  Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: evidence for a distinct response to encapsulated strains.

Authors:  Hester J Bootsma; Michael Egmont-Petersen; Peter W M Hermans
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.